Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
American Journal of Physiology. Heart and Circulatory Physiology|November 1, 2003
Novel anti-inflammatory actions of amlodipine in a rat model of arteriosclerosis induced by long-term inhibition of nitric oxide synthesisChu Kataoka, Kensuke Egashira, Minako Ishibashi, et al.The International Journal of Cardiovascular Imaging|January 18, 2018
Noninvasive quantification of left-to-right shunt by phase contrast magnetic resonance imaging in secundum atrial septal defect: the effects of breath holding and comparison with invasive oximetryYuzo Yamasaki, Satoshi Kawanami, Takeshi Kamitani, et al.European Heart Journal. Acute Cardiovascular Care|March 3, 2022
Delayed administration of epinephrine is associated with worse neurological outcomes in patients with out-of-hospital cardiac arrest and initial pulseless electrical activity: insight from the nationwide multicentre observational JAAM-OHCA (Japan Association for Acute Medicine) registryNobuyuki Enzan, Ken Ichi Hiasa, Kenzo Ichimura, et al.The Journal of Emergency Medicine|August 29, 2022
Hyperoxemia is Associated With Poor Neurological Outcomes in Patients With Out-of-Hospital Cardiac Arrest Rescued by Extracorporeal Cardiopulmonary Resuscitation: Insight From the Nationwide Multicenter Observational JAAM-OHCA (Japan Association for Acute Medicine) RegistryMasaaki Nishihara, Ken-Ichi Hiasa, Nobuyuki Enzan, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 28, 2018
Recovery from left ventricular dysfunction was associated with the early introduction of heart failure medical treatment in cancer patients with anthracycline-induced cardiotoxicityKisho Ohtani, Takeo Fujino, Tomomi Ide, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|October 9, 2004
Essential role of vascular endothelial growth factor and Flt-1 signals in neointimal formation after periadventitial injuryQingwei Zhao, Kensuke Egashira, Ken-ichi Hiasa, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 12, 2002
Anti-monocyte chemoattractant protein-1 gene therapy inhibits restenotic changes (neointimal hyperplasia) after balloon injury in rats and monkeysMakoto Usui, Kensuke Egashira, Kisho Ohtani, et al.Hypertension (Dallas, Tex. : 1979)|November 2, 2002
Antiinflammatory and antiarteriosclerotic effects of pioglitazoneMinako Ishibashi, Kensuke Egashira, Ken-ichi Hiasa, et al.Circulation|May 19, 2004
Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularizationKen-ichi Hiasa, Minako Ishibashi, Kisho Ohtani, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|January 24, 2004
Monocyte chemoattractant protein-1 is an essential inflammatory mediator in angiotensin II-induced progression of established atherosclerosis in hypercholesterolemic miceWeihua Ni, Shiro Kitamoto, Minako Ishibashi, et al.Pageof 4